Title

OX40 Agonist Tumor Immunotherapy Does Not Impact Regulatory T Cell Suppressive Function.

Authors

Fanny Polesso
Minhaz Sarker
Andrew D Weinberg, Earle A. Chiles Research Institute, Providence Cancer InstituteFollow
Susan E Murray
Amy E Moran

Document Type

Article

Publication Date

8-21-2019

Publication Title

Journal of immunology (Baltimore, Md. : 1950)

Abstract

OX40 is a costimulatory molecule from the TNFR family. In mice, it is expressed on Foxp3

Clinical Institute

Cancer

Department

Earle A. Chiles Research Institute

Department

Oncology

Recommended Citation

Polesso, Fanny; Sarker, Minhaz; Weinberg, Andrew D; Murray, Susan E; and Moran, Amy E, "OX40 Agonist Tumor Immunotherapy Does Not Impact Regulatory T Cell Suppressive Function." (2019). Articles, Abstracts, and Reports. 1971.
https://digitalcommons.providence.org/publications/1971